Rhythm Biosciences Limited · ASX:RHY
Rhythm Biosciences — Corporate Update (May 2026)
9 slides from Rhythm Biosciences's corporate update, May 13, 2026
Slide 1: Quarterly Investor Webinar
For personal use only Quarterly Investor Webinar 13TH MAY 2026
Slide 2: Welcome
For personal use only Welcome 1 © Rhythm Biosciences 2026
Slide 3: Disclaimer
Disclaimer For personal use only This presentation has been prepared by Rhythm Biosciences Limited (Rhythm) and is provided for general information purposes only. No party other than Rhythm has authorised or caused the issue of this document, or takes responsibility for, or makes any statements, rep
Slide 4: David Atkins, CEO & Managing Director
For personal use only Company Update David Atkins, CEO & Managing Director 3 © Rhythm Biosciences 2026
Slide 5: Key Highlights: Executing the transition from development to commercialisation
Company Update & Key Highlights Executing the transition from development to commercialisation For personal use only 1. Regulatory and market access milestones advancing • Continued progress across regulatory pathways • NHS evaluation program commenced 2. Commercial rollout progressing • Commercial
Slide 6: Commercial Update
For personal use only Commercial Update Jackson Jones, Chief Commercial Officer 5 © Rhythm Biosciences 2026
Slide 7: Commercial Update: Building market engagement and early adoption
Commercial Update Building market engagement and early adoption For personal use only 1. Growing clinician engagement • Increasing awareness of ColoSTAT® • Positive feedback from healthcare providers 2. Early adoption underway • Initial commercial experience established • Building reference sites an
Slide 8: Questions?
For personal use only Questions? 7 © Rhythm Biosciences 2026
Slide 9: Thank you!
For personal use only Thank you! investors@rhythmbio.com www.rhythmbio.com A copy of this webinar and presentation will be available at rhythmbio.com this week.